CLL (Chronic lymphocytic leukaemia)
CLL (Chronic lymphocytic leukaemia)
Specimen Profile
Key information about this biospecimen.
About CLL (Chronic lymphocytic leukaemia)
Human biospecimens for projects involving CLL (Chronic lymphocytic leukaemia).
Sourcing Options
Reliable sourcing network and project-based documentation.
Standard Samples
Current sourceable options can be checked against your specification.
Bulk Supply
Bulk-volume sourcing may be available depending on marker, matrix and project requirements.
Custom / Prospective Collection
For projects requiring defined donor, matrix or collection criteria.
Matched / Paired Samples
Matched or longitudinal sets (e.g. disease/healthy, pre/post) can be discussed where feasible.
Define Your Requirement
Tell us the specification you need. Our team will check current sourcing options for you.
Not sure about the specification?
Our technical team can help you define the most suitable matrix, titre range, donor profile or other project requirements.
Your information will only be used for this inquiry and handled in confidence.
Sourcing & Documentation
Overseas sourcing route available
We work with trusted international partners to source high-quality biospecimens.
Source verification
Source and specification are confirmed for each project.
Documentation available by project
Supporting documentation may include matrix details, donor/cohort information, test-related or characterization information where applicable.
Supporting documentation is confirmed according to the current source and project requirements.
Intended Use & Compliance
For Research & IVD Development Use
Human biospecimens are supplied for research and IVD development purposes and are not intended for direct human use. Availability and China import eligibility are reviewed based on specimen type, source, intended use and project requirements.
Partner with XIAOPROTEIN
Need a Different Specification?
Looking for another matrix, titre range, donor profile or collection requirement? Tell us what you need.
Marker / Disease Cohort
CLL (Chronic lymphocytic leukaemia)
Matrix Options
Blood; FFPE Tissue; Fresh Frozen Tissue; PBMC; Plasma
Overview
What is this product?
CLL (Chronic lymphocytic leukaemia) disease-state specimen cohort for hematologic-oncology biomarker, immunophenotyping, molecular and assay-validation workflows.
Hematologic malignancy classification uses integrated morphology, immunophenotyping, cytogenetic/molecular and clinical data; the cohort label should not be reduced to one biomarker or assay endpoint. Matrix option(s): Blood; FFPE Tissue; Fresh Frozen Tissue; PBMC; Plasma. For assay development or validation, confirm the exact cohort/analyte definition, collection timing, handling conditions, lot availability and project-specific use restrictions.
Specimen Considerations
Sample handling considerations
Matrix option(s): Blood; FFPE Tissue; Fresh Frozen Tissue; PBMC; Plasma. Confirm histology/pathology verification, tumor percentage/necrosis where available, fixation or freezing protocol, ischemia time, block/specimen age, extraction suitability and linked stage/grade/treatment metadata.
Technical Characteristics
Sample Information
Marker / Disease Cohort
CLL (Chronic lymphocytic leukaemia)
Disease Areas
Cancer
Matrix
Blood; FFPE Tissue; Fresh Frozen Tissue; PBMC; Plasma
Application Workflow
Sample position in workflow
Collection
Characterization
Validation